10th PATIENT CENTRICITY & COLLABORATION WORLD CONGRESS 2027 EUROPE
Patient Partnership as the Engine of Innovation, Equity, and Trust
Millennium Hotel and Conference Centre Gloucester London
Day 2 - Friday 26th February 2027
Stephen O’Farrell, Executive Director, Spectrum Science
Frida Forya, Senior Quality Solutions Lead. Roche
DIGITAL TRIALS, AI GOVERNANCE & COLLABORATIVE RESEARCH
- AI‑enabled protocol optimisation that reduces burden and improves feasibility
- Digital‑first patient experience models that streamline participation
- Strengthening data integrity and governance in increasingly digital ecosystems
- Aligning global regulatory expectations for digital and decentralised research
Moderator:
Panellists:
Lara Bloom, President and CEO, The Ehlers-Danlos Society
Dr Liz Clark, Visiting Lecturer & Patient Engagement Theme Lead, King’s College London
- Moving past race and ethnicity to actively include underserved groups
- Designing decentralized trials that solve real-world obstacles
- Understanding the UK’s shift toward structured Inclusion and Diversity Plans over strict legal mandates
- Proving how true participant representation directly leads to safer, more effective medicines for the entire population.
Alison Cave, Chief Safety Officer, MHRA
- Advocacy shaping policy, reimbursement, and clinical research agendas
- Co‑creating trial designs with patient groups to improve relevance and feasibility
- Strengthening community trust through transparent, collaborative engagement
- Measuring advocacy impact through clear, meaningful indicators
Jasmine Greenamyer, VP, Global Purpose & Patient Experience, Bristol Myers Squibb
- Designing intuitive digital tools that reduce complexity and improve usability
- Automating routine tasks to reduce patient burden and streamline workflows
- Improving communication pathways between patients, sites, and sponsors
- Measuring digital satisfaction to guide continuous improvement
Senior Representative, ABPI
- Predictive modelling that identifies optimal sites and patient populations
- Diversity‑focused feasibility approaches that improve representation
- Real‑time operational insights that support proactive decision‑making
- Automated risk detection that enhances quality and compliance
CONFIRMED-ALLOCATED: Awaiting for Company Profile
- Simplifying complex information through interactive, accessible digital formats
- Improving comprehension and retention using multimedia and adaptive content
- Supporting multilingual and low‑literacy populations with tailored materials
- Ensuring compliance through secure, audit‑ready documentation
CONFIRMED-ALLOCATED: Awaiting for Company Profile
- Continuous digital engagement that strengthens patient confidence and safety
- Symptom tracking and triage tools that support early intervention
- Integrated care coordination that connects patients, sites, and providers
- Data‑driven personalisation that improves outcomes and satisfaction
- Building shared decision‑making models that elevate patient authority
- Establishing patient governance boards that influence strategic direction
- Co‑creating research priorities that reflect lived experience and unmet needs
- Creating long‑term partnership value through sustained collaboration
Hayley Chapman, Executive Director Program Operations, The Synergist
- Why our experiences really matter
- What it takes for our experiences to change our actions
- Taking a multi-dimensional approach to patient experience design
- How our health experiences can be designed to deliver a broader societal and environmental impact
Helen Balcombe, Founder, Momentum Health Experience
- Creating inclusive UX that accommodates diverse abilities and backgrounds
- Reducing digital burden through intuitive navigation and simplified workflows
- Testing usability with patient partners to ensure real‑world relevance
- Meeting accessibility standards to support equitable digital participation
- Crafting clear, empathetic messaging that supports informed decision‑making
- Designing multi‑channel communication journeys that meet patients where they are
- Addressing misinformation through proactive, evidence‑based content
- Improving comprehension and trust through consistent, transparent communication
Michael Zaiac, Head, Medical Affairs Oncology Europe & Canada, Daiichi Sankyo EuropeGunnar Schroefel, Sr Director & Head of Oncology Patient Advocacy, Daiichi Sankyo
- Advocacy shaping clinical, regulatory, and policy agendas across regions
- Building global coalitions that amplify patient voice and influence
- Strengthening research partnerships through structured collaboration models
- Measuring advocacy impact through meaningful, transparent indicators
Moderator:
Panellists:
Gunnar Philip, Head of Medical Affairs Europe Major Markets and Canada, CSL
4:40 pm - CLOSING PANEL DISCUSSION: The Future of Patient‑Centric Innovation: What Will Matter Most?
- Ethical AI and digital governance that protect patient autonomy and safety
- Global equity strategies that ensure inclusive access to research and care
- Patient‑driven research models that reshape development priorities
- The next frontier of collaboration between patients, industry, and regulators
Moderator:
Panellists:
2026 & 2027 Sponsors & Exhibitors
